[1] |
SHEN Chen, ZHOU Xian, LIU Jianping.
Database and Evaluation Methods for Chinese Herb-Drug Interactions
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 902-908.
|
[2] |
SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui.
Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919.
|
[3] |
YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan.
Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
|
[4] |
YANG Yifan, YANG Yanwei, ZHANG Di, XIE Yin, ZHANG Yong, CHEN Xulin, GAO Sutao, GENG Xingchao, QU Zhe.
Quality Control and Test Methods of Human Induced Pluripotent Stem Cells
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 728-734.
|
[5] |
REN Yuke, QU Zhe, LAI Zixuan, ZHANG Di, ZHAO Yongtian, YANG Yanwei, LI Shuangxing, HUO Guitao, ZHOU Xiaobing, LIN Zhi, GENG Xingchao.
Pharmacodynamic Evaluation of CAR-T Cell Products Based on Deep Learning Convolutional Neural Network Recognition
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 742-748.
|
[6] |
ZHANG Huiting, LI Youlin, LI Lei, YAN Yue, YAO Ting, LI Chunlei, SHI Qi.
Toxicity of Single-Dose and Repeated-Dose Administration of Guisha Zichuan Granules
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 547-553.
|
[7] |
FAN Liping, LU Shu, SUN Huiyuan.
Efficacy and Safety of Panax Quinquefolium Saponin in Adjuvant Treatment of Angina Pectoris of Coronary Heart Disease: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 570-574.
|
[8] |
WANG Jiaqing, WANG Qi, LIU Tongtong, ZHANG Dongjie, NING Xiao.
Uncertainty Evaluation for the Determination of Tacrolimus Content in Human Whole Blood by UPLC-MS/MS Method
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 386-390.
|
[9] |
ZHENG Changhui, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, WANG Hongbin, NIU Yuanfei, FU Yao, CHEN Yanjun, CAO Junling.
Quality Evaluation and Control of Bupleuri Radix Decoction Pieces Based on ‘Shape-Chemistry-Biology' Sequential Detection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 197-205.
|
[10] |
LIU Bo, YUAN Yanan, WANG Yue, CHENG Shuqian, LU Zhiguo, FAN Huihong, SUN Huimin.
Key Technologies for Quality Control of Oligonucleotide Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 1-9.
|
[11] |
NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan.
Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
|
[12] |
LI Wenlong, JIA Juanjuan, HUANG Haiwei, YAO Jing, ZHANG Chunqing, WANG Yan, ZHANG Hui.
Developments and Prospects of Radiopharmaceuticals in China
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 37-42.
|
[13] |
SUN Deyang, SUN Jiabei, LI Wenlong, JIA Juanjuan, ZHANG Wenzai, LIU Yan, HUANG Haiwei, YAO Jing.
Assignment of Chemical Reference Substance of Aminopolyether -a Key Impurity in Fludeoxyglucose [18F] Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 43-46.
|
[14] |
JIA Juanjuan, SUN Jiabei, ZHANG Wenzai, SUN Deyang, SHI Yaqin, HUANG Haiwei.
Biological Distribution of 99mTc-DMSA Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 47-52.
|
[15] |
PEI Yusheng, XU Lin, ZHAO Yuxin, CAI Tong, HUA Xiaodong.
Low Endotoxin Recovery and Mitigation Strategies
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 72-75.
|